Identifies themes and clusters of stock movements
Market TodayThemes and Stocks SummaryThematic Stock SearchClick here for daily refresh schedule
TMDI - Titan Medical Inc
$2.38
-0.47(-16.49%)9:00:00 PM 1/21/2021
Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.
Stock Chart

Summary:

  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics

Stock news

    01/11/2021TMDI
    Titan Medical Announces Filing of Preliminary Short Form Prospectus

    Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has filed a preliminary short form prospectus with applicable securities regulators in Ontario, British Columbia and Alberta in connection with its previously announced offering of 6,451,613 units of the Company ("Units") on a "bought deal" basis, at a price of US$1.55 per Unit (...

    01/5/2021TMDI
    Titan Medical Announces US$10 Million Bought Deal Offering

    Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced it has entered into an agreement with Bloom Burton Securities Inc. (the "Underwriter") pursuant to which the Underwriter has agreed to purchase, on a "bought deal" basis, 6,451,613 units of the Company (the "Units") at a price of US$1.55 per Unit (the "Offering Price") for aggregate gross proc...

    12/30/2020TMDI
    Titan Medical Provides Regulatory Update

    Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces that the Company has received a written response from the U.S. Food & Drug Administration ("FDA") to its Request for Information in accordance with Section 513(g) of the U.S. Federal Food, Drug and Cosmetic Act ("FD&C Act"), regarding the regulatory requirements applicable to its robotically a...

    12/24/2020TMDI
    Titan Medical Reports Full Compliance with Nasdaq Listing Criteria

    Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces that on December 24, 2020, the Company received written notification from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has cured the bid price deficiency and has regained full compliance with all applicable criteria for continued listing and trading on The Nasdaq Capital Market.

    12/9/2020TMDI
    Titan Medical: Driving Toward Improved Patient Outcomes Through Robotic Single Access Surgery

    Titan Medical will be speaking at the Benzinga Global Small Cap Conference taking place on December 8-9, 2020.The use of multi-port robotic surgical systems is becoming more widely adopted in urology, gynecology, and general surgery. This type of surgical procedure (multi-port) is performed by making multiple incisions for insertion points into the body.Robotic-assisted abdominal surgery is only expected to grow. In fact, the global surgical robotics market is estimated to be about $12 billion b...

    12/7/2020TMDI
    Microbix Announces Addition to Board of Directors

    Appointment of Anthony J. Giovinazzo, Accomplished Life Sciences LeaderMISSISSAUGA, Ontario, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that Mr. Anthony J. Giovinazzo, an accomplished leader in the international life sciences industry, has joined its Board of Directors. Mr. Giovinazzo joined the Board of Directors effective today, and was also appointed as a member of the Audit Committee and t...